Carl Peck, MD
Dr. Peck joined the FDA as Director, Center for Drug Evaluation and Research, in October 1987 and was named Assistant Surgeon General for the United States in October 1990. In 1994, Dr. Peck joined the faculty of the Georgetown University Medical Center, where he is the founding Director of the Center for Drug Development Science (CDDS); in 2004, CDDS became affiliated with the UCSF School of Pharmacy. He obtained his MD from the University of Kansas in 1968, trained in internal medicine and undertook a research fellowship in clinical pharmacology at the University of California, San Francisco. In 1980, Dr. Peck became Director of the Division of Clinical Pharmacology and Professor, Departments of Medicine and Pharmacology, Uniformed Services University, Bethesda, Maryland. In 1999, Commissioner Henney presented him with the FDA Distinguished Alumnus Award. Dr. Peck is currently the Chairman of NDA Partners, LLC.

John Quackenbush, PhD
Dr. Quackenbush is a Professor of Computational Biology and Bioinformatics at the Harvard School of Public Health and Professor of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute.  Since his 1992 receipt of a five-year fellowship from the National Center for Human Genome Research to study various aspects of genomics, Dr. Quackenbush has been widely recognized as a pioneer in the area of biological data management, analysis and interpretation.  He is currently looking at patterns of gene expression in cancer, with the goal of elucidating the networks and pathways that are critical in the development and progression of the disease.  Dr. Quackenbush completed a Ph.D. in theoretical physics in 1990, followed by a two-year postdoctoral position in experimental particle physics and phenomenology.  He has held positions at The Salk Institute, Stanford University and The Institute for Genomic Research (TIGR) and is currently a member of two National Research Council panels.

Lawrence A. Rheins, PhD
Dr. Rheins is currently Vice President of Science and Technology at Floratech International, a specialty skin and personal care raw materials company.  In 1996, he founded DermTech International and served as the company’s CEO until 1999.  Thereafter, he served as Executive Vice President until DermTech’s clinical operations were sold in 2004.  Prior to founding DermTech, Dr. Rheins was Executive Director at Advanced Tissue Sciences, Technical Director at Hill Top Research and Manager of the Skin Care Laboratory at The Procter and Gamble Company. He is co-inventor of DermTech’s proprietary Epidermal Genetic Information Retrieval technology and the author of over 50 articles and book chapters on immunology, toxicology, dermatology and in vitro alternatives.  Dr. Rheins received his Bachelor of Science, Master of Science and PhD (immunology) degrees from the University of Cincinnati.  

William Wachsman, MD, PhD
Dr. Wachsman is an Associate Professor of Medicine in the Division of Hematology-Oncology at the University of California, San Diego School of Medicine and Staff Physician in the VA San Diego Healthcare System. His expertise is in the areas of microarray technology and biomarker discovery. Dr. Wachsman directs the Microarray Shared Resource and leads the AIDS-related Malignancy Specialized Cancer Unit at Moores Cancer Center at UCSD. He is also Associate Director of the GeneChip Core Laboratory and Staff Physician at the VA San Diego Healthcare System and Attending Medical Staff at UCSD Medical Center. Dr. Wachsman has received numerous fellowships and honors in the medical field and authored 60 publications as well as being named as inventor on two patents. Dr. Wachsman received his B.S., M.D. and Ph.D. degrees from Case Western Reserve University.